Instagram Links
Last Chance to Give to TAG in 2024
STAT News Story on 2024 TB Research Funding Trends Report
2024 Report on TB Research Funding Trends
Community Trainings on Drug-Resistant TB
Cheat Sheets for Tuberculosis Activists
Giving Tuesday 2024 — Donate to TAG
Delamanid Statement – 1/4/6×24 Campaign
Finally, Children of All Ages Can Benefit from 3HP to Prevent TB!
TAG Statement on the Global Fund and Other Funding Sources to Fight TB, HIV, and Other Pandemics
“Freaked Out by the U.S. Election Results?” Mark Harrington in The Body
Program – The Union World Conference on Lung Health
Webinar: WHO Guidelines on DR-TB
Statement from TAG on WHO’s 2024 Global Tuberculosis Report
Research in Action Awards 2024
Webinar Registration: Benefits and Tradeoffs of Point-of-Care Testing
Braidwood v. Becerra Amicus Brief
Cure Related Research Resources
NOW Is the Time for Hepatitis C Virus Elimination
Gilead Deal to Expand Access to Lenacapavir for PrEP Falls Short
The Body: HIV, Health Advocates Try to Stop “Catastrophic” Closing of Key Drug Access Initiative
Statement on the UN High Level Meeting on Antimicrobial Resistance Final Draft Political Declaration
AMR Accelerator in Nature Reviews Drug Discovery
Speed-Up, Scale-Up TB Diagnostics Webinar
Proposed Funding Cuts to Key Health Programs
Guardian article: Inclusion of pregnant people in TB research
Devex: IMPAACT4TB Consortium Work on TB Prevention in Zimbabwe
TAG, MSF & PIH Brief on Danaher Audit
TB CAB Announces New Website and Members
TAG Calls for Coordinated Global Response to Mpox Emergency
Target TB Regimen Profiles – WHO
Guided Tour of Peter Hujar’s “Rialto” Exhibit for AIDS Activists
Give Now and Have Your Donation Doubled
Call for New Global Long Acting Technologies CAB Members
TAG Elects Three New Board Members
Expanding Inclusion in Long-Acting HIV Treatment Trials
TAG’s Pride Health Fair in LGBTQ Nation
Open Position: Administrative Coordinator
Call for New Global TB CAB Members
TAG Calls on Danaher to Drop Price of GeneXpert Tests
Independent Panel Progress Report on Global Pandemic Preparedness + Response
Blog entry explaining June 17 Cure Trials Update
Open Letter to Médecins Sans Frontières
TAG Statement on Lenacapavir PrEP
Frequently Asked Questions on Microarray Patches (MAPs)
SMART4TB Webinar: Pregnant People in TB Research
TAG Comment at the UN High-Level Meeting on Antimicrobial Resistance Hearing
Mike Frick Comments at WHO Director General’s TB Vaccine Accelerator Council
AVAC Webinar: SMART4TB Model of Community Participation in Research
Lizzy Lovinger to UN: AMR Response Must Include DR-TB
Statement: TAG Calls on NY City Council to Override Cuts to NYC HIV Funding
Director of Development Job Post
Webinar: Community Engagement on Microarray Patches
ANEA Congressional Briefing on Ending the HIV Epidemic (EHE)
Video: How to Give Child-Friendly TPT to Kids
Preferences of Patients and Providers on Malaria Chemoprevention
IMPAACT4TB Community Statement on Child-Friendly Rifapentine
Why Hepatitis C Virus Care Remains Inaccessible
1/4/6×24 Mid-Campaign Report Launch Webinar
Danaher/Cepheid Time for $5 Petition
Getting Better Faster – Delivering on the Promise of New TB Treatments
Webinar: 1/4/6×24 Mid-Campaign Report
ANEA Webinar: Texas Strike Force’s Success Story and Strategies for State-Level Impact
National Coalition for LGBTQ Health webinar
2024 CROI Tuberculosis Research Roundup
Policy Issue Briefs: BARDA and ARPA-H
UN Human Rights Council Presentation on the Right to Participate in Science
Mike Frick Quoted in ReliefWeb
HPV Awareness Day Call to Action
TB Vax 101 вебинар на русском языке
Webinar: Effective Approaches to Engaging HIV Positive Homeless Populations
TAG Announces New Board Leadership
Melissa Barber and TAG re: J&J on Twitter/X
TAG Statement on 2024 National Black HIV/AIDS Awareness Day
DOJ + HHS Letter to State Medicaid Programs on HCV Treatment
TAG + ITPC TB Discussion at Union Conference
TAG’s HIV Basic Science, Vaccines, and Cure Project Blog
Statement on H56:Ic31 IIb Trial Results
Give Now — Ensure That We Can Continue Our Work
In Memoriam – Nancy Brooks Brody
Webinar Recording: Community Update on AbbVie’s HIV Cure Research Program
Communities as Actors in the Research and Development Process
TB CAB Comment on Expanding Treatment for DR-TB
Moulin Rouge! The Musical Sings for TB Elimination
2023 Report on TB Research Funding Trends
TAGline Issue #1, February 18, 1992
Demographics of Participation in HIV Cure-Related Research
Submission on the Right to Access and Take Part in Scientific Progress
Long-Acting TB Treatment Survey
An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis
Stigma Conference Registration
Activism Delivers Unprecedented Victories in TB Testing and Treatment Access
Treatment Action Group Calls for Immediate Ceasefire in Gaza to Protect Health and Lives
TAG Condemns GSK Actions Surrounding Potential TB Vaccine Revealed by Bombshell ProPublica Report
Lizzy Lovinger Interviewed about TB in NYC on WCBS Radio New York
October 2023 TAGline: Lost in Translation
Elizabeth Lovinger Quoted in Politico
TAG Reacts to J&J Commitment to Not Enforce Patents on Bedaquiline
Research in Action Awards (RIAA) 2023
Video: TAG’s David Branigan at the UN HLM
TAG Response to TB Preventive Therapy Price Cut Announcement from USAID and PEPFAR
Far Off Track: Funding for TB Research, 2018-2022
TAG Reaction to the Price of GeneXpert Tests
Webinar – HCV Elimination Among People Living with and at Risk of HIV: Challenges and Opportunities
September 2023 Issue of Public Health Action
Moulin Rouge! The Musical Fundraiser for TB Elimination Fundraiser
Information Note: New Fair Share Funding Targets for TB Research
TAG Mourns the Loss of Dr. Stephaun Wallace
The Lancet: Diagnostics to Support the Scaling Up of Shorter, Safer TB Regimens
Open Letter: Requesting Clarification on the Recent Deal on Generic Bedaquiline Supply